- Home
- ZKIN vs SPRB Comparison
ZKIN vs SPRB Comparison
Compare ZKIN & SPRB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ZKIN
- SPRB
- Stock Information
- Founded
- ZKIN 2015
- SPRB 2014
- Country
- ZKIN China
- SPRB United States
- Employees
- ZKIN N/A
- SPRB N/A
- Industry
- ZKIN Metal Fabrications
- SPRB Medicinal Chemicals and Botanical Products
- Sector
- ZKIN Industrials
- SPRB Health Care
- Exchange
- ZKIN Nasdaq
- SPRB Nasdaq
- Market Cap
- ZKIN 19.8M
- SPRB 22.8M
- IPO Year
- ZKIN 2017
- SPRB 2020
- Fundamental
- Price
- ZKIN $0.52
- SPRB $0.49
- Analyst Decision
- ZKIN
- SPRB Hold
- Analyst Count
- ZKIN 0
- SPRB 7
- Target Price
- ZKIN N/A
- SPRB $2.50
- AVG Volume (30 Days)
- ZKIN 94.3K
- SPRB 364.9K
- Earning Date
- ZKIN 09-30-2024
- SPRB 11-11-2024
- Dividend Yield
- ZKIN N/A
- SPRB N/A
- EPS Growth
- ZKIN N/A
- SPRB N/A
- EPS
- ZKIN N/A
- SPRB N/A
- Revenue
- ZKIN $114,831,443.00
- SPRB $7,101,000.00
- Revenue This Year
- ZKIN N/A
- SPRB N/A
- Revenue Next Year
- ZKIN N/A
- SPRB N/A
- P/E Ratio
- ZKIN N/A
- SPRB N/A
- Revenue Growth
- ZKIN 5.20
- SPRB N/A
- 52 Week Low
- ZKIN $0.38
- SPRB $0.41
- 52 Week High
- ZKIN $1.35
- SPRB $5.95
- Technical
- Relative Strength Index (RSI)
- ZKIN 46.96
- SPRB 43.61
- Support Level
- ZKIN $0.49
- SPRB $0.47
- Resistance Level
- ZKIN $0.58
- SPRB $0.51
- Average True Range (ATR)
- ZKIN 0.06
- SPRB 0.03
- MACD
- ZKIN -0.00
- SPRB -0.01
- Stochastic Oscillator
- ZKIN 34.52
- SPRB 21.35
About ZKIN ZK International Group Co. Ltd
ZK International Group Co Ltd is engaged in the manufacture and marketing of metal pipes. The company is specialized in producing double-press thin-walled stainless steel tubes and fittings, carbon steel tubes and fittings, single-press tubes and fittings, and stainless-steel strips. The products are used in restaurants, hotels, hospitals, firefighting, food, beverage, ships, engines, industrial seawater desalination and systems of direct-drinking water, cold /hot water supply, city water supply, and gas of large/middle scale construction projects.
About SPRB Spruce Biosciences Inc.
Spruce Biosciences Inc is a late-stage biopharmaceutical company focused on developing and commercializing novel therapies for rare endocrine disorders with unmet medical needs. The company is initially developing its wholly-owned product candidate, tildacerfont, as the potential first non-steroidal therapy to offer markedly improved disease control and reduce steroid burden for patients suffering from classic congenital adrenal hyperplasia (CAH).